BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7062254)

  • 1. Effect of albumin conformation on binding of phenylbutazone and oxyphenbutazone to human serum albumin.
    Abd Elbary A; Vallner JJ; Whitworth CW
    J Pharm Sci; 1982 Feb; 71(2):241-4. PubMed ID: 7062254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The measurement of binding constants using circular dichroism. Binding of phenylbutazone and oxyphenbutazone.
    Rosen A
    Biochem Pharmacol; 1970 Jun; 19(6):2075-81. PubMed ID: 5513975
    [No Abstract]   [Full Text] [Related]  

  • 3. A supercritical fluid chromatographic method using packed columns for phenylbutazone and oxyphenbutazone in serum, and for phenylbutazone in a dosage form.
    Simmons BR; Jagota NK; Stewart JT
    J Pharm Biomed Anal; 1995 Jan; 13(1):59-64. PubMed ID: 7718635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of albumin conformation on the binding of warfarin to human serum albumin. The dependence of the binding of warfarin to human serum albumin on the hydrogen, calcium, and chloride ion concentrations as studied by circular dichroism, fluorescence, and equilibrium dialysis.
    Wilting J; van der Giesen WF; Janssen LH; Weideman MM; Otagiri M; Perrin JH
    J Biol Chem; 1980 Apr; 255(7):3032-7. PubMed ID: 7358725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding of sodium warfarin to plasma albumin and its displacement by phenylbutazone.
    O'Reilly RA
    Ann N Y Acad Sci; 1973 Nov; 226():293-308. PubMed ID: 4520398
    [No Abstract]   [Full Text] [Related]  

  • 6. Allosteric properties of the oxyphenbutazone--human serum albumin complex.
    Dröge JH; Janssen LH; Wilting J
    Pharm Weekbl Sci; 1983 Oct; 5(5):228-33. PubMed ID: 6646989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study on the allosteric interaction between the major binding sites of human serum albumin using microcalorimetry.
    Dröge JH; Janssen LH; Wilting J
    Biochim Biophys Acta; 1985 Mar; 827(3):396-402. PubMed ID: 3970944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences of the N-B transition of albumin for the binding of warfarin in human serum.
    van der Giesen WF; Wilting J
    Biochem Pharmacol; 1983 Jan; 32(2):281-5. PubMed ID: 6870956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical studies into the nature of the high affinity binding site of human serum albumin for phenylbutazone.
    Maes V; Hoebeke J; Vercruysse A; Kanarek L
    Mol Pharmacol; 1979 Jul; 16(1):147-53. PubMed ID: 481416
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of albumin conformation in the binding of diazepam to human serum albumin.
    Wilting J; Hart BJ; De Gier JJ
    Biochim Biophys Acta; 1980 Dec; 626(2):291-8. PubMed ID: 7213648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenytoin binding to human albumin.
    Lecomte M; Zini R; d'Athis P; Tillement JP
    Eur J Drug Metab Pharmacokinet; 1979; 4(1):23-8. PubMed ID: 467465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of sodium aurothiomalate to human serum albumin in vitro at physiological conditions.
    Pedersen SM
    Ann Rheum Dis; 1986 Sep; 45(9):712-7. PubMed ID: 3094464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of bumadizone, phenylbutazone and oxyphenbutazone in human plasma by high-performance liquid chromatography (author's transl)].
    Spahn H; Mutschler E
    Arzneimittelforschung; 1981; 31(3):495-9. PubMed ID: 6894379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the fatty acid-induced heterogeneity of the N and B conformations of human serum albumin.
    Dröge JH; Janssen LH; Wilting J
    Biochem Pharmacol; 1985 Sep; 34(18):3299-304. PubMed ID: 4038338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of benzothiadiazides with human serum albumin studied by dialysis and spectroscopic methods.
    Takamura N; Rahman MH; Yamasaki K; Tsuruoka M; Otagiri M
    Pharm Res; 1994 Oct; 11(10):1452-7. PubMed ID: 7855051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of N-B transition of human serum albumin on the specific drug-binding sites.
    Wanwimolruk S; Birkett DJ
    Biochim Biophys Acta; 1982 Dec; 709(2):247-55. PubMed ID: 6185151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of high affinity binding sites of non-steroidal anti-inflammatory drugs with respect to site-specific probes on human serum albumin.
    Rahman MH; Yamasaki K; Shin YH; Lin CC; Otagiri M
    Biol Pharm Bull; 1993 Nov; 16(11):1169-74. PubMed ID: 8312878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of phenylbutazone and oxyphenbutazone in plasma by high-speed liquid chromatography.
    Pound NJ; Sears RW
    J Pharm Sci; 1975 Feb; 64(2):284-7. PubMed ID: 1127584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of pH on the binding of suramin to human serum albumin.
    Vansterkenburg EL; Wilting J; Janssen LH
    Biochem Pharmacol; 1989 Sep; 38(18):3029-35. PubMed ID: 2783157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid-phase extraction for the high-performance liquid chromatographic determination of indomethacin, suxibuzone, phenylbutazone and oxyphenbutazone in plasma, avoiding degradation of compounds.
    Caturla MC; Cusido E
    J Chromatogr; 1992 Oct; 581(1):101-7. PubMed ID: 1429991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.